S&P Futures
3,859.00 +10.75 (+0.28%) Dow Futures
31,093.00 +80.00 (+0.26%) Nasdaq Futures
11,928.00 +47.75 (+0.40%) Russell 2000 Futures
1,735.00 +6.40 (+0.37%) Crude Oil
98.71 +0.18 (+0.18%) Gold
1,745.00 +8.50 (+0.49%)
Viveve Medical, Inc. (VIVE)
After hours:
- ACCESSWIRE
Viveve to Participate in H.C. Wainwright Global Investment Conference
ENGLEWOOD, CO / ACCESSWIRE / May 17, 2022 / Viveve Medical, Inc. (NASDAQ:VIVE), a medical technology company focused on women's health, today announced that Scott Durbin, chief executive officer, will participate in the H.
- ACCESSWIRE
Viveve CEO Scott Durbin Named Among Top 50 Healthcare Technology Leaders of 2022 by Healthcare Technology Report
Durbin recognized for second consecutive year for leading development of Viveve's innovative technology for treatment of stress urinary incontinence in womenENGLEWOOD, CO / ACCESSWIRE / May 17, 2022 / Viveve Medical, Inc. (NASDAQ:VIVE), a medical technology company focused on women's intimate health, announced today that Scott Durbin, the Company's Chief Executive Officer, has been named by Healthcare Technology Report as one of The Top 50 Healthcare Technology CEOs of 2022.
- ACCESSWIRE
Viveve Reports First Quarter 2022 Financial Results and Provides Corporate Update
6 million in Q1 including sale of 2,750 consumable treatment tipsPURSUIT trial top-line results anticipated at end of 2022Conference call to be hosted by Company at 5:00 PM ET todayENGLEWOOD, CO / ACCESSWIRE / May 12, 2022/ Viveve Medical, Inc. (NASDAQ:VIVE), a medical technology company focused on women's intimate health, today reported financial results for the quarter ended March 31, 2022, and will provide a corporate update on its scheduled conference call at 5:00 PM ET today.
